Annals of Clinical Microbiology and Antimicrobials

Papers
(The H4-Index of Annals of Clinical Microbiology and Antimicrobials is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
COVID-19: breaking down a global health crisis199
Clinical features, hospitalisation and deaths associated with monkeypox: a systematic review and meta-analysis85
Monkeypox outbreaks during COVID-19 pandemic: are we looking at an independent phenomenon or an overlapping pandemic?63
Bacteriophage therapy for inhibition of multi drug‐resistant uropathogenic bacteria: a narrative review45
Correlation between antimicrobial resistance and biofilm formation capability among Klebsiella pneumoniae strains isolated from hospitalized patients in Iran37
Repurposing of antibiotics for clinical management of COVID-19: a narrative review34
Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study33
Molecular characteristics of antibiotic-resistant Escherichia coli and Klebsiella pneumoniae strains isolated from hospitalized patients in Tehran, Iran32
Antimicrobial susceptibility of gram-positive and gram-negative bacteria: a 5-year retrospective analysis at a multi-hospital healthcare system in Saudi Arabia32
Evaluation of Rapid Sepsityper® protocol and specific MBT-Sepsityper module (Bruker Daltonics) for the rapid diagnosis of bacteremia and fungemia by MALDI-TOF-MS29
High frequency of multidrug-resistant (MDR) Klebsiella pneumoniae harboring several β-lactamase and integron genes collected from several hospitals in the north of Iran29
Secondary bacterial infections and antimicrobial resistance in COVID-19: comparative evaluation of pre-pandemic and pandemic-era, a retrospective single center study27
Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy26
The face of hypervirulent Klebsiella pneumoniae isolated from clinical samples of two Iranian teaching hospitals26
MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges26
An overview of genes and mutations associated with Chlamydiae species’ resistance to antibiotics25
The impact of urine microbiota in patients with lower urinary tract symptoms23
Significant contribution of the CmeABC Efflux pump in high-level resistance to ciprofloxacin and tetracycline in Campylobacter jejuni and Campylobacter coli clinical isolates22
The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis22
Evaluation of efflux pump activity and biofilm formation in multidrug resistant clinical isolates of Pseudomonas aeruginosa isolated from a Federal Medical Center in Nigeria21
The laboratory findings and different COVID-19 severities: a systematic review and meta-analysis21
0.035482168197632